T
34.79
-0.12 (-0.34%)
| Previous Close | 34.91 |
| Open | 35.24 |
| Volume | 1,159,994 |
| Avg. Volume (3M) | 2,016,220 |
| Market Cap | 5,477,546,496 |
| Price / Sales | 10.35 |
| Price / Book | 100.48 |
| 52 Weeks Range | |
| Earnings Date | 4 Nov 2024 |
| Profit Margin | -116.06% |
| Operating Margin (TTM) | -29.63% |
| Diluted EPS (TTM) | -5.16 |
| Quarterly Revenue Growth (YOY) | 33.00% |
| Total Debt/Equity (MRQ) | 877.65% |
| Current Ratio (MRQ) | 2.69 |
| Operating Cash Flow (TTM) | -190.06 M |
| Levered Free Cash Flow (TTM) | 67.09 M |
| Return on Assets (TTM) | -58.65% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Health Information Services (US) | Mixed | Bearish |
| Health Information Services (Global) | Mixed | Bearish | |
| Stock | Tempus AI, Inc. | Bullish | - |
AIStockmoo Score
0.6
| Analyst Consensus | 3.0 |
| Insider Activity | -3.5 |
| Price Volatility | 1.5 |
| Technical Moving Averages | 2.5 |
| Technical Oscillators | -0.5 |
| Average | 0.60 |
|
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal. |
|
| Sector | Healthcare |
| Industry | Health Information Services |
| Investment Style | Small Growth |
| % Held by Insiders | 57.79% |
| % Held by Institutions | 30.24% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Revolution Growth Management Company, Inc. | 30 Sep 2024 | 3,660,948 |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 74.00 (Guggenheim, 112.71%) | Buy |
| Median | 62.50 (79.65%) | |
| Low | 54.00 (B of A Securities, 55.22%) | Hold |
| Average | 63.33 (82.04%) | |
| Total | 3 Buy, 3 Hold | |
| Avg. Price @ Call | 53.47 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| B of A Securities | 13 Dec 2024 | 54.00 (55.22%) | Hold | 41.00 |
| 02 Oct 2024 | 60.00 (72.46%) | Hold | 51.25 | |
| Wolfe Research | 13 Dec 2024 | 60.00 (72.46%) | Buy | 41.00 |
| Guggenheim | 09 Dec 2024 | 74.00 (112.70%) | Buy | 46.50 |
| Piper Sandler | 12 Nov 2024 | 70.00 (101.21%) | Hold | 68.04 |
| Stifel | 11 Nov 2024 | 65.00 (86.84%) | Hold | 77.62 |
| Loop Capital | 15 Oct 2024 | 57.00 (63.84%) | Buy | 46.63 |
| Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
|---|---|---|---|---|
| BARTOLUCCI RYAN M | - | 39.88 | -339 | -13,519 |
| FUKUSHIMA RYAN | - | 39.88 | -3,500 | -139,580 |
| LEFKOFSKY ERIC P | - | 34.30 | -187,655 | -6,435,628 |
| PHELPS ERIK | - | 40.94 | -12,660 | -526,538 |
| POLOVIN ANDREW | - | 39.88 | -1,130 | -45,064 |
| ROGERS JAMES WILLIAM | - | 39.88 | -1,468 | -58,544 |
| Aggregate Net Quantity | -206,752 | |||
| Aggregate Net Value ($) | -7,218,874 | |||
| Aggregate Avg. Buy ($) | - | |||
| Aggregate Avg. Sell ($) | 39.38 | |||
| Name | Holder | Date | Type | Quantity | Price | Value ($) |
|---|---|---|---|---|---|---|
| LEFKOFSKY ERIC P | Officer | 18 Dec 2024 | Automatic sell (-) | 187,655 | 34.30 | 6,435,628 |
| BARTOLUCCI RYAN M | Officer | 16 Dec 2024 | Sell (-) | 339 | 39.88 | 13,519 |
| ROGERS JAMES WILLIAM | Officer | 16 Dec 2024 | Sell (-) | 1,468 | 39.88 | 58,544 |
| FUKUSHIMA RYAN | Officer | 16 Dec 2024 | Sell (-) | 3,500 | 39.88 | 139,580 |
| POLOVIN ANDREW | Officer | 16 Dec 2024 | Sell (-) | 1,130 | 39.88 | 45,064 |
| PHELPS ERIK | Officer | 16 Dec 2024 | Sell (-) | 2,396 | 39.88 | 95,552 |
| PHELPS ERIK | Officer | 12 Dec 2024 | Automatic sell (-) | 10,264 | 41.99 | 430,985 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2024 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |